89
Views
3
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Value of systemic inflammation-response index in predicting contrast-induced nephropathy in patients with ST-elevation myocardial infarction

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 930-936 | Received 15 Mar 2023, Accepted 19 May 2023, Published online: 09 Jun 2023

References

  • Pattharanitima P, Tasanarong A. Pharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int. 2014;2014:236930.
  • Azzalini L, Candilio L, McCullough PA, et al. Current risk of contrast-induced acute kidney injury after coronary angiography and intervention: a reappraisal of the literature. Can J Cardiol. 2017;33(10):1225–1228.
  • Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020; 18(1):400.
  • Yildirim E, Ermis E, Cengiz M. Inflammatory markers of contrast-induced nephropathy in patients with acute coronary syndrome. Coron Artery Dis. 2020;31(3):279–283.
  • Zdziechowska M, Gluba-Brzózka A, Franczyk B, et al. Biochemical markers in the prediction of contrast-induced acute kidney injury. Curr Med Chem. 2021;28(6):1234–1250.
  • Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140.
  • Zhou Q, Su S, You W, et al. Systemic inflammation response index as a prognostic marker in cancer patients: a systematic review and meta-analysis of 38 cohorts. Dose Response. 2021;19(4):15593258211064744.
  • Zhang Y, Xing Z, Zhou K, et al. The predictive role of systemic inflammation response index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997–2007.
  • Li J, Li Y, Zou Y, et al. Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail. 2022;44(1):1227–1235.
  • Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64.
  • Eng J, Wilson RF, Subramaniam RM, et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med. 2016;164(6):417–424.
  • Wong PC, Li Z, Guo J, et al. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158(2):186–192.
  • Seeliger E, Sendeski M, Rihal CS, et al. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J. 2012;33(16):2007–2015.
  • Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072.
  • Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379.
  • Lu Z, Cheng D, Yin J, et al. Antithrombin III protects against contrast-induced nephropathy. EBioMedicine. 2017;17:101–107.
  • Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.
  • Shacham Y, Leshem-Rubinow E, Steinvil A, et al. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention. Clin Exp Nephrol. 2015;19(5):838–843.
  • Karauzum I, Karauzum K, Hanci K, et al. The utility of systemic immune-inflammation index for predicting contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiorenal Med. 2022;12(2):71–80.
  • Kelesoglu S, Yilmaz Y, Elcık D, et al. Systemic immune inflammation index: a novel predictor of contrast-induced nephropathy in patients with non-ST segment elevation myocardial infarction. Angiology. 2021;72(9):889–895.
  • Ertem AG, Ozen Y, Yuksekkaya B, et al. Association of the novel inflammatory marker systemic immune-inflammation index and contrast-induced nephropathy in patients undergoing transcatheter aortic valve replacement for severe aortic stenosis. Angiology. 2022;73(5):422–430.
  • Yilmaz Y, Kelesoglu S, Kalay N. A novel predictor of contrast-induced nephropathy in patients with carotid artery disease; the systemic immune inflammation index. Angiology. 2022;73(8):781–787. 33197211061919. Online ahead of print
  • Tanık VO, Cınar T, Velibey Y, et al. Neutrophil-to-lymphocyte ratio predicts contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. J Tehran Heart Cent. 2019;14(2):59–66.
  • Kurtul A, Yarlioglues M, Duran M, et al. Association of neutrophil-to-lymphocyte ratio with contrast-induced nephropathy in patients with non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention. Heart Lung Circ. 2016;25(7):683–690.
  • Kaya A, Kaya Y, Topçu S, et al. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65(1):51–56.
  • Yuan Y, Qiu H, Hu X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol. 2017; 40(9):719–725.
  • Wu X, Ma C, Sun D, et al. Inflammatory indicators and hematological indices in contrast-induced nehphropathy among patients receiving coronary intervention: a systemic review and meta-analysis. Angiology. 2021; 72(9):867–877.
  • Tekesin A, Tunç A. Inflammatory markers are beneficial in the early stages of cerebral venous thrombosis. Arq Neuropsiquiatr. 2019;77(2):101–105.
  • Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677.
  • Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–1399.
  • Carnevalini M, Giorgi M, Waldman S, et al. Contrast induced nephropathy in acute coronary syndrome. Medicina (B Aires). 2011;71(5):441–448.
  • Neves D, Belo A, Damasio AF, et al. Acute kidney injury in acute coronary syndromes - An important multifactorial consequence. Rev Port Cardiol. 2016;35(7–8):415–421.
  • Moitinho MS, Junior JRD, Cunha MDB, et al. Contrast-induced acute kidney injury in patients submitted to coronary angioplasty: prospective cohort. Rev Esc Enferm USP. 2022;56(spe):e20210435.
  • Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105(5):624–628.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.